busulfan has been researched along with Red-Cell Aplasia, Pure in 2 studies
Red-Cell Aplasia, Pure: Suppression of erythropoiesis with little or no abnormality of leukocyte or platelet production.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deotare, UR | 1 |
| Vishwabandya, A | 1 |
| Mathews, V | 1 |
| George, B | 1 |
| Srivastava, A | 1 |
| Chandy, M | 1 |
| Zhu, KE | 1 |
| Li, JP | 1 |
| Zhang, T | 1 |
| Zhong, J | 1 |
| Chen, J | 1 |
2 other studies available for busulfan and Red-Cell Aplasia, Pure
| Article | Year |
|---|---|
Response to high-dose dexamethasone for acquired pure red cell aplasia following ABO-mismatched allogeneic stem cell transplantation.
Topics: ABO Blood-Group System; Adult; Anti-Inflammatory Agents; Antilymphocyte Serum; Blood Group Incompati | 2006 |
Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation.
Topics: ABO Blood-Group System; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antig | 2007 |